Garcia, D. & Erkan, D. Diagnosis and management of the antiphospholipid syndrome. N. Engl. J. Med. 378, 2010–2021 (2018).

Article  CAS  PubMed  Google Scholar 

Knight, J. S., Branch, D. W. & Ortel, T. L. Antiphospholipid syndrome: advances in diagnosis, pathogenesis, and management. BMJ 380, e069717 (2023).

Article  PubMed  Google Scholar 

Andreoli, L. et al. Estimated frequency of antiphospholipid antibodies in patients with pregnancy morbidity, stroke, myocardial infarction, and deep vein thrombosis: a critical review of the literature. Arthritis Care Res. 65, 1869–1873 (2013).

Article  CAS  Google Scholar 

Sciascia, S. et al. The estimated frequency of antiphospholipid antibodies in young adults with cerebrovascular events: a systematic review. Ann. Rheum. Dis. 74, 2028–2033 (2015).

Article  CAS  PubMed  Google Scholar 

Duarte-Garcia, A. et al. The epidemiology of antiphospholipid syndrome: a population-based study. Arthritis Rheumatol. 71, 1545–1552 (2019).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ioannou, Y., Beukelman, T., Murray, M. & Erkan, D. Incidence of antiphospholipid syndrome: is estimation currently possible? Eur. J. Rheumatol. 10, 39–44 (2023).

Article  PubMed  PubMed Central  Google Scholar 

Taraborelli, M. et al. The contribution of antiphospholipid antibodies to organ damage in systemic lupus erythematosus. Lupus 25, 1365–1368 (2016).

Article  CAS  PubMed  Google Scholar 

Barbhaiya, M. et al. Efforts to better characterize “Antiphospholipid Antibody Nephropathy” for the 2023 ACR/EULAR antiphospholipid syndrome classification criteria: renal pathology subcommittee report. J. Rheumatol. 51, 150–159 (2024).

Article  PubMed  Google Scholar 

Crowther, M. et al. A comparison of two intensities of warfarin for the prevention of recurrent thrombosis in patients with the antiphospholipid antibody syndrome. N. Engl. J. Med. 18, 1133–1138 (2003).

Article  Google Scholar 

Finazzi, G. et al. A randomized clinical trial of high-intensity warfarin vs. conventional antithrombotic therapy for the prevention of recurrent thrombosis in patients with the antiphospholipid syndrome (WAPS). J. Thromb. Haemost. 3, 848–853 (2005).

Article  CAS  PubMed  Google Scholar 

Barbhaiya, M. et al. 2023 ACR/EULAR antiphospholipid syndrome classification criteria. Arthritis Rheumatol. 75, 1687–1702 (2023).

Article  PubMed  Google Scholar 

Chayoua, W. et al. Antiprothrombin antibodies induce platelet activation: a possible explanation for anti-FXa therapy failure in patients with antiphospholipid syndrome? J. Thromb. Haemost. 19, 1776–1782 (2021).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Müller-Calleja, N. et al. Lipid presentation by the protein C receptor links coagulation with autoimmunity. Science 12, eabc0956 (2021).

Article  Google Scholar 

Ruben, E. et al. The J-elongated conformation of β2-glycoprotein I predominates in solution: implications for our understanding of antiphospholipid syndrome. J. Biol. Chem. 295, 10794–10806 (2020).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kumar, S., Wulf, J. III, Basore, K. & Pozzi, N. Structural analyses of β2-glycoprotein I: is there a circular conformation? J. Thromb. Haemost. 21, 3511–3521 (2023).

Article  PubMed  Google Scholar 

Canaud, G. et al. Inhibition of the mTORC pathway in the antiphospholipid syndrome. N. Engl. J. Med. 371, 303–312 (2014).

Article  PubMed  Google Scholar 

Ramesh, S. et al. Antiphospholipid antibodies promote leukocyte-endothelial cell adhesion and thrombosis in mice by antagonizing eNOS via β2GPI and apoER2. J. Clin. Invest. 121, 120–131 (2011).

Article  CAS  PubMed  Google Scholar 

Canaud, G., Legendre, C. & Terzi, F. AKT/mTORC pathway in antiphospholipid-related vasculopathy: a new player in the game. Lupus 24, 227–230 (2015).

Article  CAS  PubMed  Google Scholar 

Long, B. R. & Leya, F. The role of antiphospholipid syndrome in cardiovascular disease. Hematol. Oncol. Clin. North. Am. 22, 79–94 (2008).

Article  PubMed  Google Scholar 

Alarcon-Segovia, D., Cardiel, M. H. & Reyes, E. Antiphospholipid arterial vasculopathy. J. Rheumatol. 16, 762–767 (1989).

CAS  PubMed  Google Scholar 

Hughson, M. D., McCarty, G. A. & Brumback, R. A. Spectrum of vascular pathology affecting patients with the antiphospholipid syndrome. Hum. Pathol. 26, 716–724 (1995).

Article  CAS  PubMed  Google Scholar 

Dorland, W. Dorland’s Illustrated Medical Dictionary 32nd edn (Saunders/Elsevier, 2012).

Calvo, F., Karras, B. T., Phillips, R., Kimball, A. M. & Wolf, F. Diagnoses, syndromes, and diseases: a knowledge representation problem. AMIA Annu. Symp. Proc. 2003, 802 (2003).

PubMed  PubMed Central  Google Scholar 

Martirosyan, A., Aminov, R. & Manukyan, G. Environmental triggers of autoreactive responses: induction of antiphospholipid antibody formation. Front. Immunol. 10, 1609 (2019).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Willis, R., Harris, E. N. & Pierangeli, S. S. Pathogenesis of the antiphospholipid syndrome. Semin. Thromb. Hemost. 38, 305–321 (2012).

Article  CAS  PubMed  Google Scholar 

Aggarwal, R. et al. Distinctions between diagnostic and classification criteria? Arthritis Care Res. 67, 891–897 (2015).

Article  Google Scholar 

Wilson, W. A. et al. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. Arthritis Rheum. 42, 1309–1311 (1999).

Article  CAS  PubMed  Google Scholar 

Miyakis, S. et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome. J. Thromb. Haemost. 4, 295–306 (2006).

Article  CAS  PubMed  Google Scholar 

Barbhaiya, M. et al. Development of a new international antiphospholipid syndrome classification criteria phase I/II report: generation and reduction of candidate criteria. Arthritis Care Res. 73, 1490–1501 (2021).

Article  Google Scholar 

Kelchtermans, H., Pelkmans, L., de Laat, B. & Devreese, K. M. IgG/IgM antiphospholipid antibodies present in the classification criteria for the antiphospholipid syndrome: a critical review of their association with thrombosis. J. Thromb. Haemost. 14, 1530–1548 (2016).

Article  CAS  PubMed  Google Scholar 

Chayoua, W. et al. The (non-)sense of detecting anti-cardiolipin and anti-β2glycoprotein I IgM antibodies in the antiphospholipid syndrome. J. Thromb. Haemost. 18, 169–179 (2020).

Article  CAS  PubMed  Google Scholar 

Galli, M. & Barbui, T. Antiphospholipid antibodies and thrombosis: strength of association. Hematol. J. 4, 180–186 (2003).

Article  CAS  PubMed  Google Scholar 

Brusch, A., Bundell, C. & Hollingsworth, P. Immunoglobulin G is the only anti-beta-2-glycoprotein I isotype that associates with unprovoked thrombotic events among hospital patients. Pathology 46, 234–239 (2014).

Article  CAS  PubMed  Google Scholar 

Zuo, Y. et al. Prevalence of antiphospholipid antibodies and association with incident cardiovascular events. JAMA Netw. Open. 6, e236530 (2023).

Article  PubMed  PubMed Central  Google Scholar 

Cuadrado, M. J. et al. Can anticoagulation be withdrawn in APS patients after aPL negativization? Autoimmun. Rev. https://doi.org/10.1016/j.autrev.2023.103427 (2023).

Erkan, D. et al. Real-world experience with antiphospholipid antibody tests: how stable are results over time? Ann. Rheum. Dis. 64, 1321–1325 (2005).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Vandevelde, A. et al. Semiquantitative interpretation of anticardiolipin and antiβ2glycoprotein I antibodies measured with various analytical platforms: communication from the ISTH SSC subcommittee on lupus anticoagulant/antiphospholipid antibodies. J. Thromb. Haemost. 20, 508–524 (2022).

Article  CAS  PubMed  Google Scholar 

Erkan, D. et al. Response to: correspondence on ‘2023 ACR/EULAR antiphospholipid syndrome classification criteria’ by Miro-Mur et al. Ann Rheum Dis. 83, e3 (2024).

van den Hoogen, F. et al. 2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League against Rheumatism collaborative initiative. Arthritis Rheum. 65, 2737–2747 (2013).

Article  PubMed  PubMed Central  Google Scholar 

Lundberg, I. E. et al. 2017 European League Against Rheumatism/American College of rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups. Arthritis Rheumatol. 69, 2271–2282 (2017).

Article  PubMed  PubMed Central  Google Scholar 

Roubey, R. A., Eisenberg, R. A., Harper, M. F. & Winfield, J. B. “Anticardiolipin” autoantibodies recognize beta 2-glycoprotein I in the absence of phospholipid. Importance of Ag density and bivalent binding. J. Immunol. 154, 954–960 (1995).

Article  CAS